16 April 2021>: Clinical Research
An Observational Cohort Study of the 2-Month Use of Regional Citrate Anticoagulation in Maintenance Hemodialysis Patients with Cerebral Hemorrhage
Xiao Bi ABCDEF , Qi Zhang ABE , Feng Zhuang B , Wei Lu B , Yingdeng Wang AE , Feng Ding ADE*DOI: 10.12659/MSM.930513
Med Sci Monit 2021; 27:e930513
Table 1 Baseline characteristics of patients included in the cohort.
Parameter | Normal range | Mean (SD) |
---|---|---|
Age (years) | / | 65±17 |
Gender (Male, %) | / | 57% |
White blood cell (×10/L) | 3.5–9.5 | 5.1±1.4 |
Hemoglobin (g/L) | 130–175 | 90±12 |
Hematocrit (%) | 40–50 | 28±4 |
ALT (U/L) | 10–49 | 10±2 |
AST (U/L) | 0–34 | 17±2 |
Bilirubin (mmol/L) | 5–21 | 6±3 |
Albumin (g/L) | 35–50 | 37±4 |
BUN (mmol/L) | 2.5–6.4 | 25.2±7.6 |
Scr (umol/L) | 55–96 | 657±274 |
Serum phosphate (mmol/L) | 0.78–1.65 | 1.7±0.4 |
Serum total calcium (mmol/L) | 2.08–2.65 | 2.4±0.4 |
SD – standard deviation; ALT – alanine aminotransferase; AST – aspartate aminotransferase; BUN – blood urea nitrogen; Scr – serum creatine. |